MD Anderson Helps Pfizer, J&J Play Catch-up In Cancer Immunotherapy
This article was originally published in The Pink Sheet Daily
Executive Summary
MD Anderson Cancer Center has signed research collaborations with the two big pharmas as part of a broader effort to develop novel cancer immunotherapies or combinations.
You may also be interested in...
Champagne Flows As CTLA-4/PD-1 Pioneers Allison And Honjo Win Nobel Prize
Joint prize for MD Anderson's James Allison and Kyoto University's Tasuku Honjo for checkpoint immunotherapy reflects decades of research and billions of IO dollars for industry.
Champagne Flows As CTLA-4/PD-1 Pioneers Allison And Honjo Win Nobel Prize
Joint prize for MD Anderson's James Allison and Kyoto University's Tasuku Honjo for checkpoint immunotherapy reflects decades of research and billions of IO dollars for industry.
Personal Care Next Target For UK Competition Authority ‘Greenwashing’ Audit
Manufacturers of UK personal care products watch out, the Competition and Markets Authority is on the look-out for false, exaggerated and/or vague sustainability claims, and may be targeting bigger players to make an example for the rest of the sector. And consumer health might be next. HBW Insight returns to advice from marketing expert Jo Stephenson on how to avoid greenwashing, based on the CMA's own extensive Green Claims Code.